bioMerieux (FR:BIM) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
bioMérieux, a prominent player in the biotech industry, has released its monthly report detailing 118,361,220 shares and a total of 191,139,182 theoretical voting rights as of September 30, 2024. This report aligns with regulatory compliance for voting rights and share numbers under French Commercial Code and Financial Markets Authority regulations.
For further insights into FR:BIM stock, check out TipRanks’ Stock Analysis page.